Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves FASENRA for Severe Eosinophilic Asthma

americanpharmaceuticacreviewNovember 16, 2017

Tag: FDA , FASENRA , Severe Eosinophilic Asthma

PharmaSources Customer Service